Accordingly, Nrf2 activation has been shown in mouse models to mitigate the progression of various neurodegenerative disorders: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis [61]. This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.